Director/PDMR Shareholding

RNS Number : 2388E
Dechra Pharmaceuticals PLC
07 April 2014
 





 

 

 

7 April 2014

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

 

Director / PDMR shareholding

 

 

 

Grant of SAYE options:

 

Dechra Pharmaceuticals PLC announces that on 7 April 2014, the following Directors and PDMRs were granted options over ordinary shares of 1p each in the Companypursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the "Options").

 

The Options have been granted with an exercise price of £5.52.

 

 

 

Name

Capacity

Options Granted

Ian Page

Director

1,630

Anne-Francoise Nesmes

Director

1,630

Zoe Goulding

PDMR

   652

 

 

 

For further information, please contact:

 

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKODBNBKDQQK
UK 100

Latest directors dealings